Pyxis Oncology (PYXS) Tax Rate (2024 - 2025)
Pyxis Oncology (PYXS) reported Tax Rate of 6.57% for Q4 2025, down 1230.0% year-over-year from 0.58% in Q4 2024, and down 214.56% quarter-over-quarter from 5.73% in Q4 2024.
Pyxis Oncology (PYXS) Tax Rate (2024 - 2025) Analysis & Trends
Pyxis Oncology (PYXS) has 2 years of Tax Rate data on file, last reported at 6.57% in Q4 2025.
- Tax Rate for Q4 2025 came in at 6.57%, down 1230.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 1.33% (changed N/A YoY), and the FY2025 annual result was 1.79%, down 451.0% from the prior year.
- Tax Rate slipped to 6.57% in Q4 2025 per PYXS's latest filing, from 5.73% in the prior quarter.
- Over five years, Tax Rate peaked at 5.73% in Q4 2024 and troughed at 6.57% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Pyxis Oncology | 125.84 Mn | 108.95 Mn | 8.65 Mn | -6.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.57% |
| Dec 31, 2025 | -6.57% |
| Dec 31, 2024 | 5.73% |
| Dec 31, 2024 | 5.73% |